AVITA Medical (RCEL) Long-Term Investments (2021 - 2023)

AVITA Medical (RCEL) has 3 years of Long-Term Investments data on file, last reported at $2.8 million in Q2 2023.

• For the quarter ending Q2 2023, Long-Term Investments fell 59.16% year-over-year to $2.8 million; the trailing twelve-month figure through Jun 2023 stood at $2.8 million (down 59.16% YoY), and the FY2022 full-year result was $6.9 million, down 64.81% from the prior year.
• Long-Term Investments for Q2 2023 stood at $2.8 million, down from $4.2 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $19.8 million in Q3 2021 and bottomed at $2.8 million in Q2 2023.
• The 3-year median for Long-Term Investments is $6.8 million (2022), against an average of $9.5 million.
• The widest annual swing landed in 2022, when Long-Term Investments slumped 79.74%; it then sank 59.16% in 2023.
• A 3-year view of Long-Term Investments shows it stood at $19.7 million in 2021, then slumped by 64.81% to $6.9 million in 2022, then plunged by 60.26% to $2.8 million in 2023.
• The last three Long-Term Investments figures came in at $2.8 million (Q2 2023), $4.2 million (Q1 2023), and $6.9 million (Q4 2022), per Business Quant data.

Peer Comparison